index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Human Umbilical Vein Endothelial Cells Multi resolution modeling Long QT CaVβs Cell Line Cell homeostasis Invivo Multi exon skipping DMO Immunoglobulin Fc Fragments/pharmacology Muscle Biology MiARN Muscular Dystrophy Humans Calcium DHPR α1S Muscle Mice Genomic Becker muscular dystrophy BMD Becker muscular dystrophy Dystrophie Musculaire de Becker BMD Dystrophie Musculaire de Duchenne DMD Dystrophin LncARN Mitochondrial fission Skeletal muscle Cell Biology Hepatocellular carcinoma Activin Receptors Allele‐specific silencing therapy Multiresolution modeling Becker BMD muscular dystrophy Centronuclear myopathy Muscle development NAD+ Autophagy Myotendinous junction Muscle Strength Duchenne muscular dystrophy LncRNA Hear Exon skipping Gene modifiers Cells Energy Metabolism/drug effects Gene expression Liver MES Morphogenesis Animal/physiopathology NNOS Cardiomyopathy CaV subunits Modificateurs de gènes Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Génomique Muscular Atrophy Antisense oligonucleotides Cultured DMD Base Sequence Homeostasis Calcium Channels Diseases Cachexia Epigenetics Dystrophine Molecular docking Drp1 Gene Expression Regulation/drug effects Muscles/physiopathology Ex-vivo CTNNB1 Male Muscular dystrophy Metabolism Molecular Sequence Data CD38 Delivery Myogenesis Inbred C57BL Knockout Clinical trials Mdx mouse Animals BMD Cardiomyopathie Long noncoding RNA Dystrophie musculaire de Becker Inhibitors Dystrophin central domain Dystrophy Dystrophin-EGFP Duchenne DMD dystrophy Inbred mdx L-Type Duchenne muscular dystrophy DMD LKB1 Dynamin 2